Evidence map›Paper›PMID 22038301›Full record

ReviewCell biochemistry and biophysics2013

Neovascularization and hematopoietic stem cells.

Jingwei Lu, Vincent J Pompili, Hiranmoy Das

Open access · greenAbstract readReview
In one paragraph

Review in Cell biochemistry and biophysics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Fibromodulin Enhances Angiogenesis during Cutaneous Wound Healing.Plastic and reconstructive surgery. Global open · 2014
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jingwei LuCardiovascular Stem Cell Research Laboratory, The Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Medical Center, 460W, 12th Avenue, BRT 382, Columbus, OH, 43210, USA.
Vincent J Pompili
Hiranmoy Das
The Ohio State University Wexner Medical Center · USThe Ohio State University · US

Funding

Therapeutic Potential of Ex vivo expanded Human Cord Blood derived CD133+ cells iR44HL092706 · NHLBI · ARTERIOCYTE, INC. · PI COOPER, CHRISTOPHER J, POMPILI, VINCENT J · 2008 to 2011
$2.5M
KLF2 as a novel regular for monocyte activation and functionK01AR054114 · NIAMS · OHIO STATE UNIVERSITY · PI DAS, HIRANMOY · 2008 to 2012
$670k
NHLBI NIH HHS R44 HL092706NHLBI NIH HHS R44 HL092706-01NIAMS NIH HHS K01 AR054114
6 · The paper itself

Abstract

Vasculogenesis and angiogenesis are the major forms of blood vessel formation. Angiogenesis is the process where new vessels grow from pre-existing blood vessels, and is very important in the functional recovery of pathological conditions, such as wound healing and ischemic heart diseases. The development of better animal model and imaging technologies in past decades has greatly enriched our understanding on vasculogenesis and angiogenesis processes. Hypoxia turned out to be an important driving force for angiogenesis in various ischemic conditions. It stimulates expression of many growth factors like vascular endothelial growth factor, platelet-derived growth factor, insulin-like growth factor, and fibroblast growth factor, which play critical role in induction of angiogenesis. Other cellular components like monocytes, T cells, neutrophils, and platelets also play significant role in induction and regulation of angiogenesis. Various stem/progenitor cells also being recruited to the ischemic sites play crucial role in the angiogenesis process. Pre-clinical studies showed that stem/progenitor cells with/without combination of growth factors induce neovascularization in the ischemic tissues in various animal models. In this review, we will discuss about the fundamental factors that regulate the angiogenesis process and the use of stem cells as therapeutic regime for the treatment of ischemic diseases.

Indexed as

Neovascularization, PhysiologicAnimalsCell HypoxiaHematopoietic Stem CellsHumansImmunityIntercellular Signaling Peptides and ProteinsSignal TransductionIntercellular Signaling Peptides and Proteins

Identifiers

PMID22038301
PMCPMC9930439
OpenAlexW2031762271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.